{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T21:39:30Z","timestamp":1761946770164,"version":"3.37.3"},"reference-count":19,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2015,7,1]],"date-time":"2015-07-01T00:00:00Z","timestamp":1435708800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,7,1]],"date-time":"2015-07-01T00:00:00Z","timestamp":1435708800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["jpet.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"published-print":{"date-parts":[[2015,7]]},"DOI":"10.1124\/jpet.115.224493","type":"journal-article","created":{"date-parts":[[2015,5,12]],"date-time":"2015-05-12T01:52:00Z","timestamp":1431395520000},"page":"73-78","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Humanized Thymidine Kinase\u2013NOG Mice Can Be Used to Identify Drugs That Cause Animal-Specific Hepatotoxicity: A Case Study with Furosemide"],"prefix":"10.1016","volume":"354","author":[{"given":"Dan","family":"Xu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sara A.","family":"Michie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ming","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Saori","family":"Takeda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manhong","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gary","family":"Peltz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1124\/jpet.115.224493_bib1","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1097\/00008571-200006000-00009","article-title":"Molecular genetic basis for deficient acetaminophen glucuronidation by cats: UGT1A6 is a pseudogene, and evidence for reduced diversity of expressed hepatic UGT1A isoforms","volume":"10","author":"Court","year":"2000","journal-title":"Pharmacogenetics"},{"key":"10.1124\/jpet.115.224493_bib2","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/j.bbrc.2011.01.042","article-title":"The reconstituted \u2018humanized liver\u2019 in TK-NOG mice is mature and functional","volume":"405","author":"Hasegawa","year":"2011","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1124\/jpet.115.224493_bib3","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1097\/FPC.0b013e32835cb2c7","article-title":"Human pharmacogenetic analysis in chimeric mice with \u2018humanized livers\u2019","volume":"23","author":"Hu","year":"2013","journal-title":"Pharmacogenet Genomics"},{"key":"10.1124\/jpet.115.224493_bib4","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1177\/019262339802600504","article-title":"Interspecies differences in renal localization of cyclooxygenase isoforms: implications in nonsteroidal antiinflammatory drug-related nephrotoxicity","volume":"26","author":"Khan","year":"1998","journal-title":"Toxicol Pathol"},{"key":"10.1124\/jpet.115.224493_bib5","doi-asserted-by":"crossref","first-page":"e1000412","DOI":"10.1371\/journal.pbio.1000412","article-title":"Improving bioscience research reporting: the ARRIVE guidelines for reporting animal research","volume":"8","author":"Kilkenny","year":"2010","journal-title":"PLoS Biol"},{"key":"10.1124\/jpet.115.224493_bib6","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/S0022-3565(25)30654-3","article-title":"Metabolic activation of furosemide to a chemically reactive, hepatotoxic metabolite","volume":"199","author":"Mitchell","year":"1976","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.115.224493_bib7","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1038\/251508a0","article-title":"Hepatic necrosis caused by furosemide","volume":"251","author":"Mitchell","year":"1974","journal-title":"Nature"},{"key":"10.1124\/jpet.115.224493_bib8","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1124\/jpet.112.198697","article-title":"Using chimeric mice with humanized livers to predict human drug metabolism and a drug-drug interaction","volume":"344","author":"Nishimura","year":"2013","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.115.224493_bib9","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.tips.2013.03.005","article-title":"Can \u2018humanized\u2019 mice improve drug development in the 21st century?","volume":"34","author":"Peltz","year":"2013","journal-title":"Trends Pharmacol Sci"},{"key":"10.1124\/jpet.115.224493_bib10","first-page":"381","article-title":"Furosemide (frusemide). A pharmacokinetic\/pharmacodynamic review (Part I)","volume":"18","author":"Ponto","year":"1990","journal-title":"Clin Pharmacokinet"},{"key":"10.1124\/jpet.115.224493_bib11","first-page":"460","article-title":"Furosemide (frusemide). A pharmacokinetic\/pharmacodynamic review (Part II)","volume":"18","author":"Ponto","year":"1990","journal-title":"Clin Pharmacokinet"},{"key":"10.1124\/jpet.115.224493_bib12","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/0041-008X(77)90161-2","article-title":"The role of biliary excretion in the hepatotoxicity of furosemide in the mouse","volume":"39","author":"Spitznagle","year":"1977","journal-title":"Toxicol Appl Pharmacol"},{"key":"10.1124\/jpet.115.224493_bib13","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/j.semnephrol.2011.09.006","article-title":"Intravenous high-dose furosemide and hypertonic saline solutions for refractory heart failure and ascites","volume":"31","author":"Tuttolomondo","year":"2011","journal-title":"Semin Nephrol"},{"key":"10.1124\/jpet.115.224493_bib14","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1002\/path.1711350407","article-title":"Furosemide induced hepatotoxicity","volume":"135","author":"Walker","year":"1981","journal-title":"J Pathol"},{"key":"10.1124\/jpet.115.224493_bib15","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1124\/jpet.107.125302","article-title":"The metabolism and toxicity of furosemide in the Wistar rat and CD-1 mouse: a chemical and biochemical definition of the toxicophore","volume":"322","author":"Williams","year":"2007","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.115.224493_bib16","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/S0378-4274(00)00218-6","article-title":"The role of mitochondrial injury in bromobenzene and furosemide induced hepatotoxicity","volume":"116","author":"Wong","year":"2000","journal-title":"Toxicol Lett"},{"key":"10.1124\/jpet.115.224493_bib17","doi-asserted-by":"crossref","first-page":"e1001628","DOI":"10.1371\/journal.pmed.1001628","article-title":"Fialuridine induces acute liver failure in chimeric TK-NOG mice: a model for detecting hepatic drug toxicity prior to human testing","volume":"11","author":"Xu","year":"2014","journal-title":"PLoS Med"},{"doi-asserted-by":"crossref","unstructured":"Xu D, Peltz G (2015) Can humanized mice predict drug behavior in humans? Annu Rev Pharmacol Toxicol DOI:10.1146\/annurev-pharmtox-010715-103644.","key":"10.1124\/jpet.115.224493_bib18","DOI":"10.1146\/annurev-pharmtox-010715-103644"},{"key":"10.1124\/jpet.115.224493_bib19","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1124\/jpet.114.220798","article-title":"Chimeric TK-NOG mice: a predictive model for cholestatic human liver toxicity","volume":"352","author":"Xu","year":"2015","journal-title":"J Pharmacol Exp Ther"}],"container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356524190593?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356524190593?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/jpet.115.224493","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T18:00:21Z","timestamp":1739988021000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022356524190593"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,7]]},"references-count":19,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,7]]}},"alternative-id":["S0022356524190593"],"URL":"https:\/\/doi.org\/10.1124\/jpet.115.224493","relation":{},"ISSN":["0022-3565"],"issn-type":[{"type":"print","value":"0022-3565"}],"subject":[],"published":{"date-parts":[[2015,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Humanized Thymidine Kinase\u2013NOG Mice Can Be Used to Identify Drugs That Cause Animal-Specific Hepatotoxicity: A Case Study with Furosemide","name":"articletitle","label":"Article Title"},{"value":"The Journal of Pharmacology and Experimental Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/jpet.115.224493","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2015 by The American Society for Pharmacology and Experimental Therapeutics","name":"copyright","label":"Copyright"}]}}